08 Nov 2019
WHO: Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV Policy update (2019)
The Global TB Programme convened a GDG meeting on 14–16 May 2019, in Geneva, Switzerland, to review the evidence for the use of LF-LAM.